Technical Analysis for OMGA - Omega Therapeutics, Inc.

Grade Last Price % Change Price Change
F 2.15 -0.46% -0.01
OMGA closed down 0.46 percent on Wednesday, May 8, 2024, on 1.41 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -0.46%
Wide Bands Range Expansion -0.46%

   Recent Intraday Alerts

Alert Time
2x Volume Pace about 15 hours ago
1.5x Volume Pace about 15 hours ago
Down 5% about 15 hours ago
Fell Below Lower Bollinger Band about 15 hours ago
Lower Bollinger Band Support about 15 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Omega Therapeutics, Inc., a biotechnology company, develops genomic medicines to cure diseases. The company focuses on precision tuning to activate the human genome's native capacity to treat and cure diseases. It engages in designing, engineering, and manufacturing Epigenomic Controllers to target the GenomStats for the cell types of interest, with the ability to downregulate or upregulate genomic activity for therapeutic effect. Omega Therapeutics, Inc. was formerly known as VL42, Inc. and changed its name to Omega Therapeutics, Inc. in July 2017. The company was incorporated in 2016 and is based in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Human Genome

Is OMGA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.08
52 Week Low 1.3
Average Volume 347,810
200-Day Moving Average 3.06
50-Day Moving Average 3.12
20-Day Moving Average 2.43
10-Day Moving Average 2.35
Average True Range 0.24
RSI (14) 35.48
ADX 25.06
+DI 21.38
-DI 33.08
Chandelier Exit (Long, 3 ATRs) 2.45
Chandelier Exit (Short, 3 ATRs) 2.67
Upper Bollinger Bands 2.82
Lower Bollinger Band 2.03
Percent B (%b) 0.15
BandWidth 32.75
MACD Line -0.22
MACD Signal Line -0.24
MACD Histogram 0.0198
Fundamentals Value
Market Cap 118.28 Million
Num Shares 55.1 Million
EPS -2.08
Price-to-Earnings (P/E) Ratio -1.03
Price-to-Sales 74.95
Price-to-Book 2.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.45
Resistance 3 (R3) 2.42 2.29 2.40
Resistance 2 (R2) 2.29 2.21 2.30 2.38
Resistance 1 (R1) 2.22 2.16 2.15 2.25 2.36
Pivot Point 2.09 2.09 2.06 2.10 2.09
Support 1 (S1) 2.02 2.01 1.95 2.05 1.93
Support 2 (S2) 1.89 1.96 1.90 1.91
Support 3 (S3) 1.82 1.89 1.90
Support 4 (S4) 1.85